Atlas Trials

PFA 100 Evaluation and Reference Interval HOACNY

Clinical trial NCT06100510 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06100510
Sponsor
Hematology Oncology Associates of Central New York
Status
ENROLLING_BY_INVITATION
Phase
Phase 4
Study type
INTERVENTIONAL
Effect of Drug
Start date
2024-02-19
Primary completion
2024-10-10
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.